4 Ankylosing Spondylitis Clinical Trials in Newark, NJ (2026)

Q: How do I join a clinical trial in Newark?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you.

Recruiting Ankylosing Spondylitis Studies in Newark

NCT07060807Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Researchers are looking for other ways to treat breast cancer (BC) that is hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) and either unresectable locally a...

Newark, NJPHASE31,000 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07069712Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

GEMINI-PeriOp GC study will assess the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity of novel agents or novel combinations as perioperative treatment in participants ...

Newark, NJPHASE2100 participantsAstraZeneca

View Study Details

NCT04804202Recruiting

Virtual Cycling Environments for Persons With Parkinson Disease

This study asks three questions about Persons with Parkinson Disease that use a bicycle for exercise. 1. Does the use of virtual reality increase the intensity and and enjoyment of the experience comp...

Newark, NJNA60 participantsRutgers, The State University of New Jersey

View Study Details

NCT05332002Recruiting

sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)

The primary objective is to determine the clinical efficacy of treatment regimen in terms of objective response rate (ORR). The secondary objectives is to determine the clinical efficacy of the study ...

Newark, NJPHASE238 participantsRutgers, The State University of New Jersey

View Study Details

About Ankylosing Spondylitis Clinical Trials in Newark

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Newark, NJ. These studies are seeking a combined 1,198 participants. Research is being sponsored by Merck Sharp & Dohme LLC, AstraZeneca, Rutgers, The State University of New Jersey. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Newark — FAQ

Are there ankylosing spondylitis clinical trials in Newark?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Newark, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newark?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you about next steps.

Are clinical trials in Newark free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newark studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Newark are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated October 21, 2026 from ClinicalTrials.gov